Brokers Set Expectations for Aspen Aerogels FY2027 Earnings

Aspen Aerogels, Inc. (NYSE:ASPN) – Research analysts at B. Riley dropped their FY2027 EPS estimates for shares of Aspen Aerogels in a research report issued on Tuesday, November 5th. B. Riley analyst R. Pfingst now expects that the construction company will earn $1.64 per share for the year, down from their previous forecast of $1.79. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.10 per share.

Several other research firms have also issued reports on ASPN. TD Cowen lifted their target price on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research note on Tuesday, August 20th. Barclays started coverage on shares of Aspen Aerogels in a research report on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price objective on the stock. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research note on Thursday, October 31st. Roth Mkm reaffirmed a “buy” rating and set a $36.00 price target on shares of Aspen Aerogels in a research report on Wednesday, August 21st. Finally, Benchmark reiterated a “buy” rating and set a $14.00 price objective on shares of Aspen Aerogels in a report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $29.40.

Aspen Aerogels Trading Down 9.0 %

Shares of NYSE:ASPN opened at $16.85 on Wednesday. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $1.30 billion, a PE ratio of -1,685.00 and a beta of 2.21. Aspen Aerogels has a 12-month low of $8.76 and a 12-month high of $33.15. The business’s fifty day simple moving average is $23.58 and its 200-day simple moving average is $24.66.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. The firm had revenue of $117.80 million for the quarter, compared to the consensus estimate of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The company’s quarterly revenue was up 144.4% on a year-over-year basis. During the same period last year, the firm earned ($0.22) earnings per share.

Institutional Trading of Aspen Aerogels

Hedge funds have recently added to or reduced their stakes in the stock. Point72 Hong Kong Ltd purchased a new position in Aspen Aerogels during the second quarter worth about $84,000. nVerses Capital LLC purchased a new position in shares of Aspen Aerogels during the 2nd quarter worth approximately $95,000. Quent Capital LLC acquired a new stake in shares of Aspen Aerogels in the 3rd quarter valued at approximately $118,000. Point72 DIFC Ltd purchased a new stake in shares of Aspen Aerogels in the second quarter valued at approximately $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new stake in shares of Aspen Aerogels in the second quarter valued at approximately $145,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at $626,610.60. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.